QVIDTVM Management LLC
Follow13F filer, CIK 1912226, THE WOODLANDS, TX
QVIDTVM Management LLC reported $124,160,338 across 8 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-13.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001912226-25-000001
- Period
- 2024-12-31
- Reported value
- $124M
- Holdings
- 8
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| SOLVadded | +65,000 | $4.29M |
| ZGNadded | +83,224 | $687K |
| BRCCadded | +58,705 | $186K |
| SINGULAR GENOMICS SYSTEMS INadded | +113 | $2.19K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| WABreduced | -68,141 | -$12.9M |
| RTOreduced | -101,000 | -$2.56M |
| BIOreduced | -6,991 | -$2.3M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2024
Share positions as resolved from 13F-HR 0001912226-25-000001, largest first. % of portfolio is the value over $124,160,338, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| BIOBIO RAD LABS INC | 118,947 | $39.1M | 31.47% | -6,991 | Timeline | ||
| SOLVSOLVENTUM CORP | 562,276 | $37.1M | 29.92% | +65,000 | Timeline | ||
| RTORENTOKIL INITIAL PLC | 649,176 | $16.4M | 13.24% | -101,000 | Timeline | ||
| BRCCBRC INC | 3,278,634 | $10.4M | 8.37% | +58,705 | Timeline | ||
| XRAYDENTSPLY SIRONA INC | 458,866 | $8.71M | 7.01% | 0 | Timeline | ||
| WABWABTEC | 40,334 | $7.65M | 6.16% | -68,141 | Timeline | ||
| ZGNERMENEGILDO ZEGNA N V | 378,786 | $3.13M | 2.52% | +83,224 | Timeline | ||
| SINGULAR GENOMICS SYSTEMS INSINGULAR GENOMICS SYSTEMS IN | 83,671 | $1.63M | 1.31% | +113 |
How Q4 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001912226-25-000001 | base | 2025-02-13 | acceptance time not in the bulk data set |